Construction of a convenient system for easily screening inhibitors of mutated influenza virus neuraminidases

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 484-489

  Shigemori, Tomohiro ^a   Nagayama, Mitsuru ^a   Yamada, Junki ^a   Miura, Natsuko ^a   Yongkiettrakul, Suganya ^b   Kuroda, Kouichi ^a   Katsuragi, Tohoru ^c   Ueda, Mitsuyoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Avian influenza virus H5N1; Influenza A virus neuraminidase; Yeast surface display

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; VIRUS SIALIDASE; ZANAMIVIR;

ARTICLE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; IC 50; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; THERMOSTABILITY; YEAST CELL;

AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84888028393     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2013.10.007     Document Type: Article

References (23)

1. WHO. Influenza (Seasonal) Fact sheet 211, 2009.
2. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Brides C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
3. WHO. Pandemic (H1N1) 2009 update 112, 2009.
4. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., Naghdaliyev A., Peiris J.S., Shindo N., Soeroso S., Uyeki T.M. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 2008, 358:261-273.
5. Sheu T.G., Deyde V.M., Okomo-Adhiambo M., Garten R.J., Xu X., Bright R.A., Butler E.N., Wallis T.R., Klimov A.I., Gubareva L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52:3284-3292.
6. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., Bach V.C., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353:2667-2672.
7. Deroo T., Jou W.M., Fiers W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 1996, 14:561-569.
8. Nivitchanyong T., Yongkiettrakul S., Kramyu J., Pammemgpetch S., Wanasen N. Enhanced expression of secretable influenza virus neuraminidase in suspension mammalian cells by influenza virus nonstructural protein 1. J. Virol. Methods 2011, 178:44-51.
9. Yongkiettrakul S., Boonyapakron K., Jongkaewwattana A., Wanitchang A., Leartsakulpanich U., Chitnumsub P., Eurwilaichitr L., Yuthavong Y. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J. Virol. Methods 2009, 156:44-51.
10. Kuroda K., Ueda M. Cell surface engineering of yeast for applications in white biotechnology. Biotechnol. Lett 2011, 33:1-9.
11. Ueda M., Tanaka.A. Cell surface engineering of yeast: construction of arming yeast with biocatalyst. J. Biosci. Bioeng 2000, 90:125-136.
12. Aoki W., Yoshino Y., Morisaka H., Tsunetomo K., Koyo H., Kamiya S., Kawata N., Kuroda K., Ueda M. High-throughput screening of improved protease inhibitors using a yeast cell surface display system and a yeast cell chip. J. Biosci. Bioeng 2011, 111:16-18.
13. Chao G., Lau W.L., Hackel B.J., Sazinsky S.L., Lippow S.M., Wittrup K.D. Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. 2006, 1:755-768.
14. Inaba C., Maekawa K., Morisaka H., Kuroda K., Ueda M. Efficient synthesis of enantiomeric ethyl lactate by Candida antarctica lipase B (CALB)-displaying yeasts. Appl. Microbiol. Biotechnol. 2009, 83:859-864.
15. Lin Y., Tsumuraya T., Wakabayashi T., Shiraga S., Fujii I., Kondo A., Ueda M. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface. Appl. Microbiol. Biotechnol. 2003, 62:226-232.
16. Murai T., Ueda M., Yamamura M., Atomi H., Shibasaki Y., Kamasawa N., Osumi M., Amachi T., Tanaka A. Construction of a starch-utilizing yeast by cell surface engineering. Appl. Environ. Microbiol. 1997, 63:1362-1366.
17. Nishitani T., Shimada M., Kuroda K., Ueda M. Molecular design of yeast cell surface for adsorption and recovery of molybdenum, one of rare metals. Appl. Microbiol. Biotechnol. 2010, 86:641-648.
18. Collins P.J., Haire L.F., Lin Y.P., Liu J., Russell R.J., Walker P.A., Skehel J.J., Martin S.R., Hay A.J., Gamblinet S.J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453:1258-1261.
19. Schmidt P.M., Attwood R.M., Mohr P.G., Barrett S.A., McKimm-Breschkin J.L. A generic system for the expression and purification of soluble and stable influenza neuraminidase. PLoS One 2011, 6:e16284.
20. McKimm-Breschkin J.L., McDonald M., Blick T.J., Colman P.M. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 1996, 225:240-242.
21. Varghese J.N., Laver W.G., Colman.P.M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature 1983, 303:35-40.
22. Ardiani A., Higgins J.P., Hodge.J.W. Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res. 2010, 10:1060-1069.
23. Shibasaki S., Nomura W., Miyoshi T., Tafuku A., Sewaki S., Ueda M. An oral vaccine against candidiasis generated by yeast molecular display system. FEMS Pathog. Dis. 2013, in press.